Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns
Clinical trial NCT06985706 · RECRUITING
Trial details
- NCT number
- NCT06985706
- Sponsor
- Belfast Health and Social Care Trust
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-19
- Primary completion
- 2028-11-30
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.